Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
David Balto
Payers
4 things to watch as pharma execs head to Capitol Hill
Here are a few themes to watch for during Tuesday's Senate Finance Committee hearing, including talk of “backdoor” deals negotiated by PBMs.
Paige Minemyer
Feb 26, 2019 8:47am
With CVS-Aetna deal imminent, antitrust concerns emerge
Dec 1, 2017 11:05am
Anthem's appeals loss may not dampen insurers' M&A appetite
May 1, 2017 10:38am
Aetna-Humana trial primer: A look at how the deal evolved
Dec 5, 2016 2:11pm
Judge: Only time for one insurer merger case in 2016
Aug 4, 2016 4:38pm
Insurers may alter course to target mid-size acquisitions
Jul 25, 2016 10:59am
